Arrowhead Pharmaceuticals, Inc.
ARWR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000879407
In the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 501 institutions reported holding it in 13F filings for Q2 2026, worth $9.73B in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Arrowhead Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 257 | 266 | +9 |
| Shares | 74.6M | 77.5M | +2.87M (+3.9%) |
| Value | $2.01B | $2.37B | +$366.4M (+18.3%) |
New holders (43)
Institutions that held Arrowhead Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (34)
Institutions that held Arrowhead Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.